Clinical Trial Update: Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FSH with low-dose hCG to promote oocyte maturity while reducing hCG exposure in IVF cycles; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FSH with low-dose hCG regimen

Snippet

Sponsor: University of California, San Francisco | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2022-04-29